Biomerica BMRA 深 沪
等待开盘 12-17 09:30:00 美东时间
2.37
-0.100
-4.05%
华盛通- 最 高2.47
- 今 开2.47
- 成交量 1.88万股
- 最 低 2.37
- 昨 收 2.47
- 总市值 698.68万
- 52周最高 10.16
- 市盈率 静 --
- 换手率 0.64%
- 52周最低 2.11
- 委 比 22.06%
- 总股本 294.80万
- 历史最高 187.12
- 量 比 0.93
- 振 幅 4.05%
- 历史最低 1.932
- 每 手 1
- 风险率 1.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
Biomerica's comprehensive portfolio of rapid diagnostic tests has been authorized by Egypt's Drug Authority, enabling mass and individual access to affordable early detection tools for cancers and chronic diseases such as colorectal, breast, prostate cancers, kidney disease, and H. pylori infection. The tests, including EZ Detect™ Colon Disease Test, Aware® Breast Self Exam, Fortel Prostate (PSA) Screening Test, Fortel Kidney Disease (Microalbumi...
12-11 13:08
Biomerica Highlights Clinical Trial Showing inFoods IBS Test Significantly Reduces Symptoms Through Guided Dietary Therapy In The Fall 2025 Issue Of Biotherapeutics Quarterly, A Henry Schein Publication
Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapy IRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc.
11-25 21:22
Biomerica Expands CDMO Services To Meet Rising Demand From Diagnostic And Biotech Companies
Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service ExpansionComprehensive CDMO services now featured on Biomerica's updated websiteIRVINE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) --
11-06 21:38
Biomerica Enters Marketing Partnership With Henry Schein To Promote Biomerica's Infoods Irritable Bowel Syndrome Test Across The United States, Excluding New York State
Biomerica, Inc. (NASDAQ:BMRA), a global biomedical company, announced today a marketing services arrangement with Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based
10-16 20:22
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.
Biomerica partners with Henry Schein to expand marketing of its inFoods® IBS test, leveraging Henry Schein's national distribution network. The collaboration aims to accelerate adoption of Biomerica's non-drug, precision-based diagnostic therapy for IBS patients. Recent clinical studies published in *Gastroenterology* show the test significantly reduces symptoms, particularly in underserved IBS-M patients. Henry Schein's expertise and reach will ...
10-16 12:19
Biomerica Reports First Quarter Fiscal 2026 Financial Results
Biomerica reported Q1 FY2026 financial results with net sales of $1.4 million, a decrease compared to $1.8 million in Q1 FY2025, due to reduced retail activity and international order timing. Despite lower sales, gross margin improved to 31% from 16% due to higher-margin product mix. Operating expenses declined to $1.5 million from $1.7 million, reflecting cost reduction efforts. The company achieved a net profit of approximately $2,000, compared...
10-15 13:27
Biomerica Q1 Sales $1.380M Down From $1.807M YoY
Biomerica (NASDAQ:BMRA) reported $1.380 million in sales this quarter. This is a 23.63 percent decrease over sales of $1.807 million the same period last year.
10-15 06:01
Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes
Biomerica launched the inFoods® IBS Trigger Food Navigator, an AI-powered tool to help IBS patients manage symptoms and avoid trigger foods identified by the inFoods® IBS test. With more than 40 million adults in the U.S. affected by IBS, the tool offers personalized meal suggestions, ingredient substitutions, and simplified meal planning. It has shown significant clinical benefits, including a 59.6% reduction in abdominal pain compared to tradit...
09-09 12:08
Biomerica shares are trading higher after the UAE Ministry of Health and Prevention approved the company's Fortel Kidney Test for home use.
Biomerica shares are trading higher after the UAE Ministry of Health and Preven...
09-03 20:20
